Inventor
RAI ROOPA
US26 patents
⚠️ This page may combine multiple inventors who share the name “RAI ROOPA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MEDIVATION TECH LLC
5 patentsUS10030004B2Jul 24, 2018
Compounds and methods of use
MEDIVATION TECH LLC6 citations81
US11702401B2Jul 18, 2023
Compounds and methods of use
MEDIVATION TECH LLC0 citations60
US11053216B2Jul 6, 2021
Compounds and methods of use
MEDIVATION TECH LLC0 citations60
US10501436B2Dec 10, 2019
Compounds and methods of use
MEDIVATION TECH LLC0 citations49
US10189826B2Jan 29, 2019
Heterocyclic compounds and methods of use
MEDIVATION TECH LLC0 citations32
MEDIVATION TECHNOLOGIES INC
3 patentsUS9670172B2Jun 6, 2017
Heterocyclic compounds and methods of use
MEDIVATION TECHNOLOGIES INC2 citations68
US9422267B2Aug 23, 2016
Fused pyrimidine compounds and use thereof
MEDIVATION TECHNOLOGIES INC0 citations51
US9499519B2Nov 22, 2016
Fused pyrimidine compounds and use thereof
MEDIVATION TECHNOLOGIES INC0 citations50
MYOFORTE THERAPEUTICS INC
3 patentsUS12559493B2Feb 24, 2026
PGDH inhibitors and methods of making and using
MYOFORTE THERAPEUTICS INC0 citations59
US11891389B2Feb 6, 2024
PGDH inhibitors and methods of making and using
MYOFORTE THERAPEUTICS INC0 citations59
US11345702B1May 31, 2022
PGDH inhibitors and methods of making and using
MYOFORTE THERAPEUTICS INC1 citations59
ASSEMBLY BIOSCIENCES INC
3 patentsUS12030869B2Jul 9, 2024
5-membered heteroaryl carboxamide compounds for treatment of HBV
ASSEMBLY BIOSCIENCES INC0 citations59
US11560370B1Jan 24, 2023
5-membered heteroaryl carboxamide compounds for treatment of HBV
ASSEMBLY BIOSCIENCES INC1 citations59
US11078170B2Aug 3, 2021
Cyclic sulfamide compounds and methods of using same
ASSEMBLY BIOSCIENCES INC1 citations59
PHARMACYCLICS INC
2 patentsKOLESNIKOV ALEKSANDR
2 patentsUS8299110B2Oct 30, 2012
2-(2-hydroxybiphenyl-3-yl)-1H-benzoimidazole-5-carboxamidine derivatives as factor VIIa inhibitors
KOLESNIKOV ALEKSANDR8 citations81
US8778625B2Jul 15, 2014
2-(2-hydroxybiphenyl-3-yl)-1H-Benzoimidazole-5-carboxamidine derivatives as factor VIIA inhibitors
KOLESNIKOV ALEKSANDR3 citations60